首页 | 本学科首页   官方微博 | 高级检索  
     

腺叶切除不完全分化型甲状腺癌^131I疗效观察
引用本文:傅宏亮,杜学亮,顾振辉,邹仁健,吴真,王辉. 腺叶切除不完全分化型甲状腺癌^131I疗效观察[J]. 上海交通大学学报(医学版), 2010, 0(3): 268-270
作者姓名:傅宏亮  杜学亮  顾振辉  邹仁健  吴真  王辉
作者单位:上海交通大学医学院新华医院核医学科,上海200092
基金项目:基金项目:上海市重腻孚科建设项目(S30203)
摘    要:目的研究腺叶切除不完全的分化型甲状腺癌(DTC)患者实施放射性碘(^131I)清除甲状腺组织(清甲)治疗的效果。方法回顾性分析DTC术后接受^131I清甲治疗的103例患者的临床资料。根据甲状腺平面显像结果分为腺叶切除不完全组(n=33)和腺叶切除完全组(n=70)。首次^131I清甲剂量为1.11~3.7GBq(30—100mCi)。3~6个月后复查并评估清甲效果:若诊断剂量^131I全身显像显示颈部无放射性摄取即认为清甲完全;若有放射性摄取,即认为清甲不完全,需再次行^131I清甲治疗,定期随访复查清甲效果。结果实施3次清甲治疗的成功率,腺叶切除完全组分别为61.43%、88.89%和100%,腺叶切除不完全组分别为21.21%、46.15%和78.57%。统计学分析表明,腺叶切除完全组的第1、2次清甲疗效与腺叶切除不完全组的第2、3次清甲疗效比较,差异均无统计学意义(P〉0.05)。结论对于甲状腺腺叶切除不完全的DTC患者,实施^131I治疗的一次清甲成功率较低,但经2—3次治疗后同样可达到较高的清甲疗效。尤其适用于再次手术可能会导致严重的手术并发症或拒绝再次手术的患者。

关 键 词:分化型甲状腺癌  甲状腺腺叶切除  放射性碘  清除甲状腺组织

Efficacy of ^131I thyroid remnant ablation in patients with differentiated thyroid carcinoma after partial thyroidectomy
FU Hong-liang,DU Xue-liang,GU Zhen-hui,ZOU Ren-jian,WU Zhen,WANG Hui. Efficacy of ^131I thyroid remnant ablation in patients with differentiated thyroid carcinoma after partial thyroidectomy[J]. Journal of Shanghai Jiaotong University:Medical Science, 2010, 0(3): 268-270
Authors:FU Hong-liang  DU Xue-liang  GU Zhen-hui  ZOU Ren-jian  WU Zhen  WANG Hui
Affiliation:(Department of Nuclear Medicine, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, China)
Abstract:Objective To observe the efficacy of radioactive iodine (^131 I) thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC) after partial thyroidectomy. Methods The clinical data of 103 patients with ^131I thyroid remnant ablation after DTC were retrospectively analysed. Patients were divided into partial thyroideetomy group (n = 33)and complete thyroidectomy group (n = 70)according to the findings of thyroid planar imaging. The first ablation dose was 1.11 -3.7 GBq (30 - 100 mCi). Diagnostic ^131I whole body scan was used to evaluate the efficacy of ablation 3 to 6 months later. If no visible radioactive uptake in thyroid bed was found, the ablation was defined to be complete. Otherwise, the ablation was defined to be partial, and patients needed a second or third dose of ^131I with routine follow-up. Results After the first, second and third ablation, the rates of complete ablation in complete thyroidectomy group were 61.43%, 88.89% and 100%, and those in partial thyroidectomy group were 21.21%, 46.15% and 78.57%. There was no significant difference between the efficacy of the first and second ablation in complete thyroidectomy group and that of the second and third ablation in partial thyroidectomy group ( P 〉 0.05). Conclusion The efficacy of ^131 I thyroid remnant ablation in patients with DTC after partial thyroidectomy may not be favourable at the first dose, while a high rate of complete ablation can be achieved at the second or third dose.
Keywords:differentiated thyroid carcinoma  thyroidectomy  radioiodine  thyroid remnant ablation
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号